Assertio Therapeutics Inc Cash Flow Quality Index
Assertio Therapeutics Inc cash flow quality index. Assertio Therapeutics Inc (ASRT) has a Cash Flow Quality Index of -0.42x as of September 2025. Operating cash flow of $-4.77 Million is below net income of $11.45 Million, suggesting accrual-heavy earnings not yet converted to cash. See how financially flexible is Assertio Therapeutics Inc to measure the company's free cash flow as a share of total liabilities.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Cash Flow Quality Index of Assertio Therapeutics Inc (2007–2022)
Cash flow quality index of Assertio Therapeutics Inc from 2007 to 2022. Historical Cash Flow Quality Index for Assertio Therapeutics Inc across 6 annual periods. Values consistently above 1.0x indicate high-quality earnings. Explore how well can Assertio Therapeutics Inc service its debt to assess how comfortably operating cash covers total debt obligations.
Assertio Therapeutics Inc Cash Flow Quality Index by Year (2007–2022)
Assertio Therapeutics Inc cash flow quality index by year from 2007 to 2022. Year-by-year earnings quality comparison for Assertio Therapeutics Inc. For the full cash flow conversion analysis, see ASRT cash flow metrics.
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2022 | 0.72x | $78.60 Million | $109.62 Million | ▼ -63.5% |
| 2018 | 1.96x | $72.50 Million | $36.91 Million | ▲ +407.7% |
| 2013 | 0.39x | $9.75 Million | $25.21 Million | ▼ -52.5% |
| 2011 | 0.82x | $57.65 Million | $70.73 Million | ▲ +233.4% |
| 2010 | -0.61x | $-2.38 Million | $3.90 Million | ▼ -305.2% |
| 2007 | 0.30x | $14.66 Million | $49.22 Million | — |